Now more than ever, business and government have a crucial role to play in protecting people’s health, bolstering the economy, and developing both practical solutions and game-changing innovations. At BCG, we’re working with companies and public-sector organizations around the world to manage the impact of the coronavirus, with actions ranging from rapid responses to more fundamental, strategic shifts. We’re also helping leaders look much further ahead and envision how the crisis will continue to affect the competitive environment and what society will need in the coming months and years. This page is updated frequently with the latest COVID-19 information and insights.



The How-To of Hybrid Work - Rectangle

The How-To of Hybrid Work

A systematic approach to postpandemic ways of working can capture the upsides of these models while mitigating the risks.


Leading Out of Adversity

Survival is top of mind today for many companies, but thriving is the long game. That calls on leaders to respond to a new environment, a new customer, and heightened societal expectations. Here are five imperatives for adapting to and shaping the post-COVID world.


Global Vaccines Rollout

With key lessons learned from the frontline of the COVID-19 vaccine rollout, what strategic priorities must global leaders implement to continue along the path to normality?

Download Edition 22: Global Vaccines Rollout (March 2021)





Public Sector, Health Care, and Social Impact

The coronavirus crisis has created exceptional challenges for public sector organizations and health care companies while underscoring, for all industries, the power and importance of social impact.


Reimagining Global Health After the Coronavirus

What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?


As Vaccines Roll Out, Testing Still Matters

Multiple scenarios for the US and four EU countries point to a continued need for COVID-19 testing through 2024, with demand peaking in the seasonally affected first quarters of 2021 and 2022.

Further Reading